Profil
Katherine Vega Stultz currently works at BrainXell, Inc., as Chief Executive Officer & Director from 2025.
Ms. Stultz also formerly worked at Ocelot Bio, Inc., as President & Chief Executive Officer, Kronos Bio, Inc., as Independent Director from 2023 to 2025, Celgene Corp., as VP-Global Project Leadership & Hematology, and Graphite Bio, Inc., as Chief Operating Officer from 2020 to 2021.
Ms. Stultz received her undergraduate degree from Cornell University.
Postes actifs de Katherine Stultz
| Sociétés | Poste | Début |
|---|---|---|
BrainXell, Inc.
BrainXell, Inc. Pharmaceuticals: MajorHealth Technology Develops stem cell therapy for neurological injuries and diseases | Directeur Général | 10/07/2025 |
Anciens postes connus de Katherine Stultz
| Sociétés | Poste | Fin |
|---|---|---|
| KRONOS BIO, INC. | Directeur/Membre du Conseil | 20/06/2025 |
| LENZ THERAPEUTICS, INC. | Directeur des opérations | 31/12/2021 |
| CELGENE | Corporate Officer/Principal | 01/01/2020 |
Ocelot Bio, Inc.
Ocelot Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with liver diseases | Directeur Général | - |
Formation de Katherine Stultz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kronos Bio, Inc.
Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
Graphite Bio, Inc.
Graphite Bio, Inc. BiotechnologyHealth Technology Operates as gene editing company for DNA integrations | Health Technology |
Ocelot Bio, Inc.
Ocelot Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with liver diseases | Health Technology |
BrainXell, Inc.
BrainXell, Inc. Pharmaceuticals: MajorHealth Technology Develops stem cell therapy for neurological injuries and diseases | Health Technology |
















